FIORETTO, PAOLA
FIORETTO, PAOLA
Dipartimento di Medicina - DIMED
Heterogeneity in the relationships between albuminuria and glomerular structure in type 1 and type 2 diabetes
2026 Najafian, Behzad; Caramori, Maria Luiza; Dalla Vestra, Michele; Saller, Alois; Noruzinia, Mehrdad; Mauer, Michael; Fioretto, Paola
Psychological Predictors of Poor Weight Loss Following Endoscopic Sleeve Gastroplasty
2026 Polese, Lino; Schiff, Sami; Moltrer, Francesca; Frigo, Anna Chiara; Prevedello, Luca; Pozza, Giulia; Albanese, Alice; Rampado, Sabrina; Scarda, Alessandro; Bettini, Silvia; Fioretto, Paola; Foletto, Mirto
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes
2026 Morieri, Mario Luca; Vedovato, Monica; Bonora, Benedetta Maria; Fioretto, Paola; Fadini, Gian Paolo
Association of Chrono-Nutritional Profiles with Weight Loss and Comorbidity Remission After Bariatric Surgery in Patients with Severe Obesity
2025 Bettini, S.; Carraro, E.; Pilatone, A.; Schiff, S.; Girardi, P.; D'Angelo, M.; Begolli, A.; Mansouri, F.; Toosinezhad, S.; Sandri, S.; Gusella, B.; Milan, G.; Foletto, M.; Fioretto, P.; Busetto, L.
Could the heparanase/TGF-β axis modulation be considered for the SGLT2 inhibitors cardioprotection in obesity? A hypothesis-generating report
2025 Di Vincenzo, Angelo; Crescenzi, Marika; Granzotto, Marnie; Capone, Federico; Cortese, Fausto; Fioretto, Paola; Vettor, Roberto; Rossato, Marco
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
2025 Schnell, Oliver; Almandoz, Jaime; Anderson, Lisa; Barnard-Kelly, Katharine; Battelino, Tadej; Blüher, Matthias; Busetto, Luca; Catrinou, Doina; Ceriello, Antonio; Cos, Xavier; Danne, Thomas; Dayan, Colin M.; Del Prato, Stefano; Fernández-Fernández, Beatriz; Fioretto, Paola; Forst, Thomas; Gavin, James R.; Giorgino, Francesco; Groop, Per-Henrik; Harsch, Igor A.; Heerspink, Hiddo J. L.; Heinemann, Lutz; Ibrahim, Mahmoud; Jadoul, Michel; Jarvis, Sarah; Ji, Linong; Kanumilli, Naresh; Kosiborod, Mikhail; Landmesser, Ulf; Macieira, Sofia; Mankovsky, Boris; Marx, Nikolaus; Mathieu, Chantal; Mcgowan, Barbara; Milenkovic, Tatjana; Moser, Othmar; Müller-Wieland, Dirk; Papanas, Nikolaos; Patel, Dipesh C.; Pfeiffer, Andreas F. H.; Rahelić, Dario; Rodbard, Helena W.; Rydén, Lars; Schaeffner, Elke; Spearman, C. Wendy; Stirban, Alin; Tacke, Frank; Topsever, Pinar; Van Gaal, Luc; Standl, Eberhard
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis
2025 Rossing, Peter; Birkenfeld, Andreas L; Fioretto, Paola; Mcgill, Janet B; Anker, Stefan D; Pitt, Bertram; Rohwedder, Katja; Scalise, Andrea; Scott, Charlie; Filippatos, Gerasimos
Real-world prescriptions of GLP-1RAs and SGLT2is in type 2 diabetes prioritise BMI and age over cardiorenal risk: a machine learning-based large cohort analysis
2025 Tuccinardi, Dario; Zilich, Rita; Ponzani, Paola; Musacchio, Nicoletta; Manicardi, Valeria; Rocca, Alberto; Pontremoli, Roberto; Fioretto, Paola; Muscarà, Andrea; Di Cianni, Graziano; Candido, Riccardo; De Cosmo, Salvatore A; Russo, Giuseppina
The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice
2025 Di Vincenzo, Angelo; Granzotto, Marnie; Crescenzi, Marika; Fioretto, Paola; Vettor, Roberto; Rossato, Marco
Combination therapy for kidney disease in people with diabetes mellitus
2024 van Raalte, Daniël H; Bjornstad, Petter; Cherney, David Z I; de Boer, Ian H; Fioretto, Paola; Gordin, Daniel; Persson, Frederik; Rosas, Sylvia E; Rossing, Peter; Schaub, Jennifer A; Tuttle, Katherine; Waikar, Sushrut S; Heerspink, Hiddo J L
Treatment with dapagliflozin increases FGF-21 gene expression and reduces triglycerides content in myocardial tissue of genetically obese mice
2024 Di Vincenzo, A; Crescenzi, M; Granzotto, M; Vecchiato, M; Fioretto, P; Vettor, R; Rossato, M
[Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?]
2023 Avogaro, Angelo; Corsini, Alberto; Sinagra, Gianfranco; Borghi, Claudio; Sciatti, Edoardo; Trevisan, Roberto; Fioretto, Paola; Calabrò, Paolo; Di Pasquale, Giuseppe; Senni, Michele
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table
2023 Cosentino, Francesco; Verma, Subodh; Ambery, Philip; Treppendahl, Marianne Bach; Van Eickels, Martin; Anker, Stefan D; Cecchini, Michele; Fioretto, Paola; Groop, Per-Henrik; Hess, David; Khunti, Kamlesh; Lam, Carolyn S P; Richard-Lordereau, Isabelle; Lund, Lars H; Mcgreavy, Paul; Newsome, Philip N; Sattar, Naveed; Solomon, Scott; Weidinger, Franz; Zannad, Faiez; Zeiher, Andreas
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
2023 Ebert, Thomas; Anker, Stefan D; Ruilope, Luis M; Fioretto, Paola; Fonseca, Vivian; Umpierrez, Guillermo E; Birkenfeld, Andreas L; Lawatscheck, Robert; Scott, Charlie; Rohwedder, Katja; Rossing, Peter
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia
2023 Seccia, T. M.; Shagjaa, T.; Morpurgo, M.; Caroccia, B.; Sanga, V.; Faoro, S.; Venturini, F.; Iadicicco, G.; Lococo, S.; Mazzitelli, M.; Farnia, F.; Fioretto, P.; Kobayashi, Y.; Gregori, D.; Rossi, G. P.
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
2023 Ceriello, Antonio; Lucisano, Giuseppe; Prattichizzo, Francesco; La Grotta, Rosalba; Frigé, Chiara; De Cosmo, Salvatore; Di Bartolo, Paolo; Di Cianni, Graziano; Fioretto, Paola; Giorda, Carlo Bruno; Pontremoli, Roberto; Russo, Giuseppina; Viazzi, Francesca; Nicolucci, Antonio
A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative
2022 Russo, G T; Giandalia, A; Ceriello, A; Di Bartolo, P; Di Cianni, G; Fioretto, P; Giorda, C B; Manicardi, V; Pontremoli, R; Viazzi, F; Lucisano, G; Nicolucci, A; De Cosmo, S
Expanding the therapy options for diabetic kidney disease
2022 Fioretto, P.; Pontremoli, R.
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study
2022 Morieri, M. L.; Ronco, C.; Avogaro, A.; Farnia, F.; Shestakova, M.; Zaytseva, N.; Mokrysheva, N.; Akulkina, L.; Shepalina, A.; Brovko, M.; Moiseev, S.; Russo, L.; Mazzocut, S.; Vianello, A.; Cattellan, A. M.; Vedovato, M.; Fadini, G. P.; Vettor, R.; Fioretto, P.
Potassium management with finerenone: Practical aspects
2022 Wanner, Christoph; Fioretto, Paola; Kovesdy, Csaba P; Malyszko, Jolanta; Pecoits-Filho, Roberto; Schnell, Oliver; Rossignol, Patrick